苑东生物：布瑞哌唑片获药品注册证书

Core Viewpoint - Yuan Dong Biotech (688513) has received approval from the National Medical Products Administration for the registration of its drug, Brexpiprazole Tablets, which is indicated for the treatment of adult schizophrenia [1] Company Summary - The approved drug, Brexpiprazole, contains the active ingredient brexpiprazole and is specifically aimed at treating adult patients with schizophrenia [1]